Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Pediatric Transplantation|May 6, 2004
Detection and treatment of minimal residual disease in high-risk neuroblastomaC Patrick Reynolds
Journal of the National Cancer Institute|March 7, 2002
Ras and Seppuku in neuroblastomaC Patrick Reynolds
BMJ Quality Improvement Reports|January 7, 2016
Inpatient Falls: Improving assessment, documentation, and managementEleanor Nelson, Patrick Reynolds
Continuum (Minneapolis, Minn.)|July 20, 2012
Systematic stroke preventionCheryl Bushnell, Patrick Reynolds
Neurology|January 29, 2014
Author responseRoy Strowd, Patrick Reynolds
Neurology|June 5, 2013
Opinion & special articles: the lost resident: why resident physicians still need mentoringRoy E Strowd, Patrick Reynolds
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Tirapazamine cytotoxicity for neuroblastoma is p53 dependentBo Yang, C Patrick Reynolds
Methods in Molecular Medicine|May 20, 2005
Evaluating response to antineoplastic drug combinations in tissue culture modelsC Patrick Reynolds, Barry J Maurer
Neurocritical Care|January 5, 2018
Factors Associated with the Outcome of Very Elderly Patients with Large Hemispheric Infarction Treated with Medical Management OnlySudhir Datar, Christopher McLouth, Patrick Reynolds
Molecular Cancer Therapeutics|December 17, 2010
Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteinsMichael D Hadjidaniel, C Patrick Reynolds
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Pediatric Transplantation|May 6, 2004
Detection and treatment of minimal residual disease in high-risk neuroblastomaC Patrick Reynolds
Journal of the National Cancer Institute|March 7, 2002
Ras and Seppuku in neuroblastomaC Patrick Reynolds
BMJ Quality Improvement Reports|January 7, 2016
Inpatient Falls: Improving assessment, documentation, and managementEleanor Nelson, Patrick Reynolds
Continuum (Minneapolis, Minn.)|July 20, 2012
Systematic stroke preventionCheryl Bushnell, Patrick Reynolds
Neurology|January 29, 2014
Author responseRoy Strowd, Patrick Reynolds
Neurology|June 5, 2013
Opinion & special articles: the lost resident: why resident physicians still need mentoringRoy E Strowd, Patrick Reynolds
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Tirapazamine cytotoxicity for neuroblastoma is p53 dependentBo Yang, C Patrick Reynolds
Methods in Molecular Medicine|May 20, 2005
Evaluating response to antineoplastic drug combinations in tissue culture modelsC Patrick Reynolds, Barry J Maurer
Neurocritical Care|January 5, 2018
Factors Associated with the Outcome of Very Elderly Patients with Large Hemispheric Infarction Treated with Medical Management OnlySudhir Datar, Christopher McLouth, Patrick Reynolds
Molecular Cancer Therapeutics|December 17, 2010
Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteinsMichael D Hadjidaniel, C Patrick Reynolds
Pageof 22